{"schema_version":"secwatch.filing_event.v1","accession":"0001087294-26-000043","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2026-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.931961+00:00","generated_at":"2026-05-15T04:10:07.227804+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Cumberland shareholders elect two Class I directors, ratify auditor, approve say-on-pay","bullets":["Kenneth J. Krogulski elected with 99.52% votes in favor; Caroline R. Young with 98.66%.","Ratification of Carr, Riggs & Ingram as auditor for FY 2026 received 99.82% approval.","Advisory vote on executive compensation passed with 99.82% votes in favor.","Frequency vote: every three years for say-on-pay received 7,844,848 votes vs 1,733,309 for every year.","All proposals passed; annual meeting held April 21, 2026 in Nashville, Tennessee."],"urls":{"canonical":"https://secwatch.observer/filing/0001087294-26-000043","json":"https://secwatch.observer/filing/0001087294-26-000043.json","markdown":"https://secwatch.observer/filing/0001087294-26-000043.md","text":"https://secwatch.observer/filing/0001087294-26-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000043/0001087294-26-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000043/cpix-20260421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:10:07.227804+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}